PTGS2 and skin cancer: Due to the biotransformation of DAI, this can be utilized as a chemo-preventive drug in skin cancer despite its lack of effect on cyclooxygenase 2 (COX-2) expression, its metabolite directly binding to tumor progression locus and mitogen-activated protein kinase 4 to block their activity.